MedTrace Logo

Place of Circulating Biomarkers and Respiratory Eicosanoids in the Prognosis of Severe Forms of Covid-19 Pneumonia

NCT04485364 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 97

Last updated 2023-03-07

No results posted yet for this study

Summary

The research is a prospective, multicentric (Groupe hospitalier Paris Saint-Joseph, Centre Hospitalier de Versailles André Mignot and Centre Hospitalier Victor Dupouy), non-interventional, prospective study. It aims at measuring eicosanoids at different stages of Covid-19 infection.

Conditions

  • Coronavirus
  • Covid19

Sponsors & Collaborators

  • Versailles Hospital

    collaborator OTHER

  • Centre Hospitalier Victor Dupouy

    collaborator OTHER

  • Fondation Hôpital Saint-Joseph

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-14
Primary Completion
2022-05-31
Completion
2022-06-06

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04485364 on ClinicalTrials.gov